Summary estimates: non-severe pneumonia
| Outcome | Summary estimate | Number of studies (n=participants) | Heterogeneity |
|---|---|---|---|
| Oral co-trimoxazole vs oral amoxicillin | |||
| Clinical failure | RR 1.09; 95% CI 0.93 to 1.27 | 3 (n=3759) | χ2 p 0.007; I² 80% |
| Cure rate | RR 0.99; 95% CI 0.96 to 1.01 | 2 (n=3468) | χ2 p 0.004; I² 88% |
| Oral levofloxocin vs oral co-amoxiclavulanic acid | |||
| Cure rate | RR 1.02; 95% CI 0.93 to 1.11 | 1 (n=3759) | Not applicable |
| Oral azithromycin vs oral co-amoxiclavulanic acid | |||
| Treatment failure (2 weeks) | RR 1.20; 95% CI 0.45 to 3.21 | 2 (n=276) | χ2 p 0.55; I² 0% |
| Amoxicillin vs co-amoxiclavulanic acid | |||
| Cure rate | OR 10.44; 95% CI 2.85 to 38.21 | 1 (n=100) | Not applicable |
| Parenteral Ampicillin vs penicillin plus chloramphenicol | |||
| Clinical cure | RR 0.90; 95% CI 0.76 to 1.06 | 1 (n=101) | Not applicable |
| Treatment failure | RR 1.88; 95% CI 0.69 to 5.12 | 1 (n=101) | Not applicable |